This is probably the biggest concern that every community and cancer practice should be looking at, explained Ben Jones, vice president, Government Relations & Public Policy, McKesson Specialty Health.
This is probably the biggest concern that every community and cancer practice should be looking at, explained Ben Jones, vice president, Government Relations & Public Policy, McKesson Specialty Health.
Transcript
CMS has proposed allowing step therapy in Medicare Advantage plans for Part B drugs. How do you think this will impact cancer patients?
This is probably the biggest concern that every community and cancer practice should be looking at. The president has come out with a number of proposals included in the drug pricing blueprint that have a specific impact on Part B drugs. The secretary made it clear when the drug pricing proposal was released that his desire was to, as much as his ability allows, move Part B drugs into Part D. In absent the ability to kind of make an easy shift into Part D, what he wants to do is mimic some of the characteristics that Part D has in the Part B space. That’s why you’re seeing such quick action on step therapy, on a relaxing of the protected classes, and on a number of utilization management tools that are likely to come down the pipe.
I do think that this is something that has the biggest potential to threaten access to care for cancer patients across the country. These are just 2 examples. Step therapy and protected classes have already been finalized. The changes to both of those proposals have been finalized in Medicare Advantage, but we’ve also got another proposal with the International Pricing Index that again has the potential to insert a new third-party vendor into the drug supply chain, impacting access to patient timely care and potentially a new round of utilization management tools.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More